Retour
Fourchette du Jour
36,68 €
38,27 €
Fourchette 52 Semaines
6,42 €
39,15 €
Volume
752 978
Moyenne 50J / 200J
32,17 €
/
19,01 €
Clôture Précédente
36,32 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -16,4 | 0,2 |
| P/B | 7,6 | 3,0 |
| ROE % | -39,8 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
49,80 €
+35.7%
Low: 42,00 €
High: 59,00 €
BPA Prévisionnel
-2,38 €
CA Est.
687 429,0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,96 €
-0,96 € – -0,96 €
|
243,02M | 2 |
| FY2029 |
-2,67 €
-2,67 € – -2,67 €
|
45,35M | 4 |
| FY2028 |
-2,72 €
-3,38 € – -1,10 €
|
16,52M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -0,53 € | -0,57 € | -7,2% |
| 2025-11-05 | -0,50 € | -0,50 € | 0,0% |
| 2025-08-14 | -0,53 € | -0,47 € | +11,3% |
| 2025-05-08 | -0,49 € | -0,47 € | +4,1% |
| 2025-03-27 | -0,48 € | -0,43 € | +10,4% |
| 2024-11-07 | -0,40 € | -0,41 € | -2,5% |
| 2024-08-07 | -0,41 € | -0,32 € | +22,0% |
| 2024-05-09 | -0,46 € | -0,35 € | +23,9% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -95,28M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-39,83%
ROIC-37,58%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio14,67
Interest Coverage0,00
Valorisation
P/E Ratio
-16,44
Forward P/EN/A
P/B Ratio7,61
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -119,95M |
| ROE | -39,83% | ROA | -42,44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95,28M |
| ROIC | -37,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 14,67 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -16,44 | Forward P/E | N/A |
| P/B Ratio | 7,61 | P/S Ratio | N/A |
| PEG Ratio | -0,39 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2868,02 | Fwd Earnings Yield | N/A |
| FCF Yield | -4,83% | ||
| Market Cap | 1,97B | Enterprise Value | 1,90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -119,95M | -86,48M | -69,13M | -55,33M | -26,29M |
| EPS (Diluted) | -2,01 | -1,51 | -1,62 | -1,23 | -0,63 |
| Gross Profit | -546 000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -132,76M | -104,18M | -79,95M | -58,93M | -26,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 282,61M | 363,56M | 225,86M | 266,18M | 306,70M |
| Total Liabilities | 23,43M | 20,41M | 21,60M | 8,35M | 4,96M |
| Shareholders' Equity | 259,18M | 343,15M | 204,26M | 257,83M | 301,74M |
| Total Debt | 5,81M | 6,22M | 6,50M | 2,62M | 1,18M |
| Cash & Equivalents | 77,39M | 91,97M | 58,01M | 251,21M | 302,18M |
| Current Assets | 265,45M | 347,46M | 211,67M | 257,29M | 304,06M |
| Current Liabilities | 18,09M | 14,59M | 15,33M | 5,70M | 3,62M |